Vireo is currently in early access and completely free. The first 100 subscribers keep the founding-member price permanently: €3/month (normally €5).
Vireo
/

Tord Staffan Håkan Skogvall — CEO

Get alerts when Tord Staffan Håkan Skogvall trades

Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: PharmaLundensis AB.

12-month summary

Net seller over the last 12 months

0 open-market buys, 2 sales, 0 share awards · SEK 0.00 bought, SEK 224,877.72 sold

Roles

PharmaLundensis AB Stockholm
CEO
23.09.2025 – 01.07.2026

Transactions (including via associated entities)

DateIssuerTransaction typeVolumePriceValueSource
01.07.2026PharmaLundensis AB Stockholm
SoldDisposal
148,138SEK 0.40
SEK 59,492.22
↗
04.06.2026PharmaLundensis AB Stockholm
SoldDisposal
1,181,325SEK 0.14
SEK 165,385.50
↗
20.02.2026PharmaLundensis AB Stockholm
New shares (subscription)
200,000SEK 0.50
SEK 100,000.00
↗
01.10.2025PharmaLundensis AB Stockholm
SoldDisposal
223,693SEK 0.64
SEK 143,163.52
↗
24.09.2025PharmaLundensis AB Stockholm
Bought — open marketAcquisition
92,333SEK 0.19
SEK 17,543.27
↗
24.09.2025PharmaLundensis AB Stockholm
Bought — open marketAcquisition
63,017SEK 0.22
SEK 13,863.74
↗
23.09.2025PharmaLundensis AB Stockholm
Bought — open marketAcquisition
65,656SEK 0.20
SEK 13,131.20
↗